Delivery Order SPE2DR25D1053-SPE2DR26FV407
- Not listed
- The Defense Logistics Agency awarded a $34,089.55 firm fixed-price delivery order to AmerisourceBergen Drug Corp (parent company: Cencora, Inc.) on January 9, 2026, for the supply of Repatha 140 mg/ml SureClick auto-injector medication. The contract, with an ultimate completion date of January 12, 2026, represents a non-set-aside competitive award and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $16,550.52 delivery order to AmerisourceBergen Drug Corp (parent company Cencora, Inc.) on January 8, 2026, for the supply of Repatha 140 mg/ml SureClick auto-injectors. This competitively awarded, firm fixed-price contract is scheduled for completion by January 9, 2026, and will be performed at AmerisourceBergen's headquarters in Conshohocken, Pennsylvania. The delivery order carries no set-aside designation, indicating the award was made through full...
- The Defense Logistics Agency awarded a $47,231.90 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Repatha 140 mg/ml SureClick auto-injectors. The contract, which was competitively awarded without set-aside restrictions, was executed on January 8, 2026, with an ultimate completion date of January 9, 2026. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal...
- The Defense Logistics Agency awarded a delivery order valued at $1,218.48 to AmerisourceBergen Drug Corp for Repatha 140 mg/mL SureClick auto-injectors on January 9, 2026, with an ultimate completion date of January 12, 2026. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The product will be performed and delivered from AmerisourceBergen's facility in Conshohocken, Pennsylvania. AmerisourceBergen is a subsidiary of...
- The Defense Logistics Agency awarded a $15,965.27 delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/mL SureClick auto-injectors on January 9, 2026, with completion targeted for January 12, 2026. This competitive, firm fixed-price delivery order was placed against AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 2026. The contract carries no set-aside designation, reflecting full and open...
- The Defense Logistics Agency awarded a $66,044.96 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors, with an ultimate completion date of November 10, 2025. This non-set-aside contract represents a competitive award to the pharmaceutical distributor for medical supply procurement supporting federal healthcare operations. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $32,806.01 to AmerisourceBergen Drug Corp for the supply of Repatha 140 mg/mL SureClick auto-injectors. This competitively awarded, firm fixed-price delivery order was issued on January 6, 2026, with an ultimate completion date of January 7, 2026. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs for military and veteran...
- The Defense Logistics Agency awarded a $10,178.15 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors on January 6, 2026, with an ultimate completion date of January 7, 2026. This non-competed delivery order was placed against AmerisourceBergen's parent company Cencora, Inc.'s comprehensive Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999.99 million through December 2031. Repatha is a specialty...
- The Defense Logistics Agency awarded a $32,695.44 delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors, with an ultimate completion date of January 5, 2026. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is being fulfilled from the vendor's Conshohocken, Pennsylvania facility. The award represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a $4,103.30 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 6, 2026, for the supply of Repatha 140 mg/ml SureClick auto-injectors. The contract, which is a child order under AmerisourceBergen's parent company Cencora, Inc., carries an ultimate completion date of January 7, 2026, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order was awarded through open competition with...
- SPE2DR25D1053Indefinite Delivery Contract
- SPE2DR25D1053-SPE2DR26FV407Delivery Order
The Defense Logistics Agency awarded a $35,035.90 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 9, 2026, for the supply of Repatha 140 mg/ml SureClick auto-injectors. This non-set-aside contract is scheduled for completion by January 12, 2026, with performance at the awardee's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., a major pharmaceutical distributor serving federal healthcare systems. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, a comprehensive pharmaceutical prime vendor agreement valued at up to $999,999,999.00 through December 2026. This delivery order represents a routine pharmaceutical procurement supporting military healthcare operations. Repatha is a specialty cardiovascular medication used for cholesterol management, reflecting the breadth of therapeutic products distributed through the DLA Medical Supply Chain to support the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. AmerisourceBergen's competitively awarded IDC enables efficient procurement of critical medications and medical supplies for military treatment facilities and veteran healthcare programs worldwide, with task orders like this one allowing flexible fulfillment of evolving pharmaceutical requirements across the Defense Department's healthcare infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $35.0k | 1/8/26 |